OSBPL8 and metabolic dysfunction-associated steatohepatitis: The ShOsbpl8-AAV group exhibited significant increases in the serum ALT, AST, and TG levels, whereas Osbpl8-enriched M2-BMDM-EV injection ameliorated liver injury in MASH mice (Fig. 6C).